At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 53 enrolled
Drug / intervention
Clindamycin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Placebo-controlled Double-blinded Trial of the Treatment of MRSA Throat Carriage With Either Standard Decolonization Therapy or Standard Decolonization Therapy Combined With Oral Clindamycin
In Brief
A Phase 3 clinical trial evaluating Clindamycin and Placebo for MRSA and MRSA Colonization. Completed, enrolled 53 participants across 1 site.
Detailed Summary
The aim of this study is to investigate the optimal way to treat MRSA throat carriers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMRSA, MRSA Colonization
CountriesDenmark
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartMay 2020
Primary CompletionSep 2025
TodayJul 2026
First PostedSep 26, 2019
Enrollment StartMay 20, 2020
Primary CompletionSep 18, 2025
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 6.8 years ago
Interventions
Clindamycindrug
Investigating whether a significantly higher number of MRSA throat carriers succeed in becoming MRSA free, when using Clindamycin on top of our general recommended topical treatment of Mupirocin nasal ointment + chorhexidin baths
Placebodrug
Placebo